维普中文期刊产品整合服务
19篇 您的检索式:作者名="Magny B"
    题名 作者 年代 出处 被引量
1Time-dependent spectral analysis of epidemiological time-series withwavelets显示文摘Cazelles B Chavez M De Magny G C 2007Journal of the Royal Society Interface2007,4,15:1
2Interactions between hydrophobically modified polymers and surfactants显示文摘Magny B Iliopoulous I Audebert R etal 1992Progr Coll Polym Sci1992,89,:1
3The Role of Team Behavioral Integration and Cohesion in Shaping Individual Improvisation显示文摘Magni M Proserpioa L Hoegl M Provera B 2009Research Policy2009,38,3:1
4Individual Attitude Toward Improvisation in Information Systems Development 显示文摘Magni M Provera B Proserpio L 2010Behaviour & Information Technology2010,29,3:1
5Effect of the diisocyanate on the structure and properties of polyurethane acrylate prepolymers 显示文摘BARBEAU P H GERARD J F B MAGNY B 2000Journal of Polymer Science: Part B : Polymer Phys- ics2000,38,21:1
6Mixed micelles formed by cationic surfaetants and anionic hydrophobieally modified polyelectrolytes显示文摘Magny B Iliopoulos I Zana R etal 1994Langmuir1994,10,9:1
7Use of functional (meth)acrylic cross-linked polymer microparticles as toughening agents for epoxy/diamine thermosets显示文摘Valette L Pascault 3 P Magny B 2003Macromol Mater Eng2003,288,11:1
8Early-Holocene cli- matic oscillations recorded by lake-level fluctuations in west-central Europe and in central Italy 显示文摘Magny M Vannire B De Beaulieu J L 2007Quaternary Science Reviews2007,26,1516:1
9Comparing three devices for jump height measurement in a het- erogeneous group of subjects显示文摘MAGNI~~SDOTTIR ASDIS~ ORGILSSON B KARLSSON B 2014J Strength Cond Res2014,28,10:1
10Intrinsic viscosity of hydrophobically modified polyelectrolytes 显示文摘Magny B Iliopoulos I Audibert R 1991Polym Communications1991,32,15:1
11(Meth) acrylic cross-linked polymer microparticles: synthesis by dispersion polymerization and particle characterization 显示文摘L VALETTE J - P PASCAULT B MAGNY 2002Macromol Mater Eng2002,,287:1
12The physical map of wheat chromosome 5DS revealed gene duplications and small rearrangements显示文摘AKPINAR B A MAGNI F YUCE M 2015BMC genomics2015,16,:1
13Reduced solar activity as a trigger for the start of the Younger Dryas显示文摘Renssen H van Geel B van der Plicht J Magny M 0,,:1
14Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage显示文摘Ferrero E Scabini S Magni E Foglieni C Belloni D Colombo B 2004FASEB J2004,18,:1
15In- teractions between hydrophobically modified polymers and surfactants 显示文摘MAGNY B ILIOPOULOS I AUDEBERT R 1992Progr Colloid Polym Sci1992,9,:1
16Interactions between hydrophobically modified polymers and surfactants 显示文摘Magny B Iliopoulous I Audebert R 1992Progress Colloid Polymer Science1992,89,:1
17Category specificity in object agnosia:Preservation of sensorimotor experiences related to objects显示文摘Magnie M Ferreira C Giusiano B 1999Neuropsychologia1999,37,:1
18Prospective randomized muhicenter comparison of high-frequency oscillatory ventilation and conventional ventilation in preterm infants of less than 30 weeks with respiratory distress syndrome 显示文摘Moriette G Paris-Llado J Walti H Escande B Magny JF Cam- bonie G 2001Pediatrics2001,107,2:1
19Pazopanib-induced posterior reversible encephalopathy syndrome with possible syndrome of inappropriate secretion of antidiuretic hormone: an incidental or pathophysiological association?显示文摘Introduction:Pazopanib is an oral protein kinase inhibitor(PKI)that targets vascular endothelial growth factor(VEGF)receptors,fibroblastic growth factor receptors,platelet-derived growth factor receptors,and stem cell factor that inhibits VEGF-induced cellular proliferation.Pazopanib is approved for use in advanced renal cell carcinoma and subtypes of advanced soft-tissue sarcoma(Deguchi et al.,2018).Major adverse drug reactions of pazopanib include hypertension,high-grade hyponatremia and posterior reversible encephalopathy syndrome(PRES)(Berardi et al.,2016;Deguchi et al.,2018).In clinical trials,few investigations have been conducted to determine the aetiology of PKI-associated hyponatremia,the mechanism remains therefore unknown.Only rare cases of PKI-induced syndrome of inappropriate secretion of antidiuretic hormone(SIADH)(Largeau et al.,2019),and none with pazopanib,have been reported.PRES is a clinical and radiological entity where a bilateral white matter oedema,occurring predominantly in the posterior occipital and parietal lobes,is associated with several neurologic symptoms.Interestingly,a recent review suggests that SIADH could be a symptom of PRES(Largeau et al.,2019).To our knowledge,this is the first case published where pazopanib-induced PRES occurs contemporaneously with possible SIADH.Jonathan Wong So Bérenger Largeau Frédérique Beau-Salinas Stephan Ehrmann Christophe Magni Jérome Meunier 2020Neural Regeneration Research2020,15,6:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费